NCT00087451 - Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Malignant GliomaGlioblastomaGliosarcoma

Interventions

DRUG

AP23573

ridaforolimus

Trial Locations (4)

The Brain Tumor Center at Duke, Duke University Medical Center, Durham

Brain Tumor Institute, The Cleveland Clinic, Cleveland

M.D. Anderson Cancer Center, Houston

Center For Neuro-Oncology, Dana Farber Cancer Institute, Boston